To explore which prostate cancer cell line models could be utilized to model the resistant and eradicated states, we determined the FANCI mRNA and protein expression levels in LNCaP, PC-3, 22Rv1, VCaP, and DU-145 prostate cancer cells. Here, FANCI is linked to prostate carcinoma.